Navigation Links
March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are?
Date:3/6/2009

nd the third leading cause of cancer death in both men and women in the United States, with nearly 150,000 new cases diagnosed each year. Approximately 50,000 people die from it annually.

Although colorectal cancer often has no symptoms, warning signs that may indicate colorectal cancer include blood in your stools, narrower than normal stools, unexplained abdominal pain, unexplained change in bowel habits, unexplained anemia, and unexplained weight loss. These symptoms may be caused by other benign diseases such as hemorrhoids, inflammation in the colon or irritable bowel syndrome. However, if you have any of these symptoms, you should be evaluated by your doctor.

To assist the public in understanding the different screening options available, the ASGE has developed a list summarizing recommended screening methods.

Screening is done on individuals who do not necessarily have any signs or symptoms that may indicate cancer. If symptoms exist, then diagnostic workups are done rather than screening.

Stool blood test (fecal occult blood test or FOBT):

This test is used to find small amounts of hidden (occult) blood in the stool. A sample of stool is tested for traces of blood. People having this test will receive a kit with instructions that explain how to take stool samples at home. The kit is then sent to a lab for testing. If the test is positive, further tests will be done to pinpoint the exact cause of the bleeding. A rectal exam in the doctor's office may examine for occult blood, but this is NOT considered adequate for colorectal cancer screening. The test should only be done with a take-home kit.

A newer kind of stool blood test is known as FIT (fecal immunochemical test). It is like the FOBT, perhaps even easier to do, and it gives fewer false positive results.

PROS:

  • Simple

  • '/>"/>

SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Orchid Cellmark to Announce Fourth Quarter and Year-End 2008 Financial Results on March 16, 2009
2. eDiets.com(R) to Report Fourth Quarter and Year End 2008 Results on Monday, March 16, 2009
3. Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise
4. SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern
5. BurrellesLuce VP Johna Burke to Be Featured Presenter For PRSA's March 9th Free Webinar on 'Smart Measurement'
6. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year 2008 Financial Results on Thursday, March 12, 2009
7. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
8. Journal Chest: March news briefs
9. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
10. National Multiple Sclerosis(MS) Awareness Week is March 15-21
11. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...r too heavy can lead to strains or worse , ...ay be nothing wrong with stuffing your turkey full...e thing with your suitcase as you pack for holiday...in 2008 in U.S. hospital emergency rooms, doctors,... luggage-related injuries, such as muscle strains,...
(Date:11/26/2009)... No more letters from the North Pole, Textsanta.n...ages from Santa , North P...ional efficiencies at the North Pole Santa Claus h...all over the globe informed of his Christmas progr...research department have identified a large and gr...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leading d...day announced the expansion of its services to inc.... Doug Macmillan. , Du...eased to announce that Dr. Doug Macmillan, an expe... additional advanced training seminar. RTDental&r...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationw...d Yasmin birth control pills who have suffered a D...oke, Heart Attack or other related cardiac issues ...oll free at 1-800-856-6405 or go to the firm&rsquo...ut an online case evaluation form. , ...
(Date:11/25/2009)...ov.25/PRNewswire/--TheBartleHallConventionCenterwi...onDec.9-10,whenKansasCityhoststhelatestinaseriesof...reecliniceventhasthepotentialtobethebiggestoneyet,...eheldonweekdaysinsteadofoveraweekend,"SheriWood,ex...residentoftheNationalAssociationofFreeClinics(NAFC...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
... World Available with Levemir(R), NovoLog(R) and N... Novo Nordisk has redesigned FlexPen(R), the n...rld(1), to allow diabetes patients to use less for...Novo Nordisk insulin products, Levemir(R) (insulin...
...fected, study says , , MONDAY, March 2 (He...min B12 in their blood before and after conception... or spinal cord defects, a new study says. , Mos...findings were published in the March issue of Ped...
... worrying about personal finances , , MOND...all Americans are tossing and turning, unable to g...about the economy, their jobs or their money, a ne..., according to the annual poll by the National Sle...
... , COLUMBUS, Ga., March 2 Aflac launched a new...stery benefactor to policyholders who are sick or ...ly shows how Aflac pays cash benefits when a medic...n who had an accident and cannot go to work. After...
...d to Provide Consumers a Free-of-Charge Resource f... Funeral Homes, Cremation Services and Cemeteries ...s.com ( http://www.FuneralDecisions.com ) has anno...vices. By allowing its users, free of charge, to s...
...er High-Tax Tendencies Decimate The American Healt...W TAXES, OBAMA ANNOUNCES SEBELIUS AS HHS SECRETARY...sed today by the Republican National Committee: ,... Will Nominate Gov. Kathleen Sebelius (D-KS) For H...
Other Medicine News:Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 2Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 3Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 4Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 5Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 6Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 7Health News:B12 Deficit May Boost Risk of Birth Defects 2Health News:With the Economy Down, Sleeplessness Is Up 2Health News:With the Economy Down, Sleeplessness Is Up 3Health News:New Aflac Commercial Asks, 'Who Dun It?' 2Health News:New Aflac Commercial Asks, 'Who Dun It?' 3Health News:Taking the Stress Out of Funeral Planning, FuneralDecisions.com Offers Consumers an Innovative Approach 2Health News:RNC: Wrong Prescription 2Health News:RNC: Wrong Prescription 3Health News:RNC: Wrong Prescription 4Health News:RNC: Wrong Prescription 5Health News:RNC: Wrong Prescription 6
(Date:11/25/2009)...25/PRNewswire/--RegadoBiosciences,aprivatelyheldco...withactivecontrolagents,announcedthatDavidMazzo,Ph...y21stAnnualHealthCareConferenceattheNewYorkPalaceH...nat1:10pm(EST)onTuesday,December1andwillincludeano...developmentprogram,theanticoagulantsystem,REG1.The...
(Date:11/25/2009)...5/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ...ebloodanalysissystems,announcedtodaythatClintSever...the21stAnnualPiperJaffrayHealthCareConferenceonWed...lbeheldattheNewYorkPalaceHotelinNewYorkCity. ,,...dmarketsportablebloodanalysissystemsforuseinanyvet...
(Date:11/25/2009).../PRNewswire/--CempraPharmaceuticalsInc.todayannoun...tiveofficer,willpresentatthePiperJaffray21stAnnual...tTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswi...ticclinicalprogramsforthetreatmentofdrug-resistant...uticals ,, Foundedin2006,CempraPharmaceuticals...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 1AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 3AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 4Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 1Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 2Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 1Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 2Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 4
... Dec. 9 Portola,Pharmaceuticals, a biopharmaceuti...de significant advances in cardiovascular disease,...that it has initiated patient enrollment in,INNOVA...28, the Company,s,novel P2Y12 ADP receptor antagon...s coronary intervention (PCI). , "With the i...
...nnium: The Takeda Oncology Company today reported ...ients from the large, international Phase III VIST...for patients with previously untreated multiple my...P). The VELCADE combination demonstrated consisten...ose with poor prognostic characteristics, such as ...
Other Medicine Technology:Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 2Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q51-R-PAL
BTN/1Q-CAB - Reinforced Nylon Base - Model 1Q64-R-CAB
BTN/1Q-CAB - Reinforced Nylon Base - Model 1Q72-R-CAB
BTN/1Q-CAB - Reinforced Nylon Base - Model 1Q51-R-CAB
Medicine Products: